Korea

VisualCamp wins CES Innovation Award for second consecutive year for its eye-tracking technology

SEOUL, South Korea, Nov. 17, 2022 /PRNewswire/ -- VisualCamp, a member of the Born2Global Centre (CEOKim Jong-kap), and an artificial intelligence (AI)-based eye-tracking technology startup, announced on the 17th of this month that it has won the CES Innovation Award of CES 2023, the world's larg...

2022-11-17 22:00 3262

Hyundai Heavy Industries Group Wins Nine CES 2023 Innovation Awards with Its Next Generation Technology in Green Energy and Mobility

* Five subsidiaries of Hyundai Heavy Industries Group including Korea Shipbuilding & Offshore Engineering and Hyundai Electric, receive awards for their flagship products * Hyundai Heavy Industries Group aims to lead global market by leveraging technology recognized for its potential and comp...

2022-11-17 22:00 2965

Hyundai Mobis develops the world's first IVI technology that opens quick menu with a gesture when your finger goes near the in-vehicle display

* IR proximity sensors and gesture detection enable users to select a desired menu with just one touch. * Bring your finger near the screen to automatically open the pop-up menu to maximize user convenience. * Detection algorithm and automatic monitor calibration boosts accuracy, with great...

2022-11-17 21:00 2294

Dermafirm records approx. KRW 20.8 bn in sales during the 2022 Singles' Day event in China

YOY growth increased by approx. 205% * Dermafirm participates in the 2022 Singles' Day Event on Tmall and Tiktok, recording approx.KRW 20.8 billion in sales * Bestselling imported products in the hypoallergenic cleanser and primer/makeup base categories on Tmall * Celebrity endorsement b...

2022-11-17 21:00 1746

[CES 2023] AI FOR PET NAMED AS CES 2023 INNOVATION AWARDS HONOREE

SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ -- AI FOR PET today announced that it has been named as CES 2023 Innovation Awards Honoree for TTcare. This year's CES Innovation Awards program received a record-high number of over 2100 submissions. The announcement was made ahead of CES 2023, the ...

2022-11-17 09:16 2481

Standigm Synthetic Research Center successfully accelerates drug discovery in its first year

Lab uniquely enables collaboration between chemical and AI researchers SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ -- Standigm , the workflow AI-driven drug discovery company, today announced the celebration of its Synthetic Research Center's first year. In the ...

2022-11-17 08:45 2658

SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree

SK Biopharmaceuticals is recognized in the digital health category for two wearable devices –Zero Glasses TM and Zero Wired TM – becoming the first Korean pharma to earn this accolade PANGYO, South Korea, Nov. 16, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical co...

2022-11-17 07:09 2916

Gaudio Lab Won Two "CES Innovation Awards"

SEOUL, South Korea, Nov. 16, 2022 /PRNewswire/ -- Gaudio Lab, a leading AI audio technology company, announced that it won two "CES Innovation Awards," which was held ahead of CES 2023, the world's biggest IT consumer electronics and consumer technology trade show that will take place inLas Vegas...

2022-11-17 06:30 2573

HanAll Biopharma Reports Third Quarter 2022 Results and Provides Business Update

* Financial results for Q3 2022 ended with revenue of KRW 29.6 billion with continued growth in the pharmaceutical division driven by product portfolio expansion and strong sales in major products * R&D expenses for the quarter increased by 63%, reflecting the preparation of a Phase 3 study i...

2022-11-15 20:00 1429

Daewoong Pharmaceutical Surpasses KRW 300 Billion in Q3 Revenue as Nabota Sales Grew by 93%, Leading Overall Growth in Revenue

* Nabota exports grew significantly, achieving a 93.3% growth YOY, and overall revenue topsKRW 40.4 billion * Fexuclue, a new drug released last July, shows steep growth in market share in Korea * Nabota enters the European market and Fexuclue enters wide use as in prescriptions for gastrit...

2022-11-15 20:00 1557

MakinaRocks Unveils "Runway" - Targeting the Enterprise MLOps Market

* Reduce time to build AI operational environment from 6 months to 4 weeks SEOUL, South Korea, Nov. 14, 2022 /PRNewswire/ -- AI startup MakinaRocks (Co-CEOsAndre S. Yoon and Jae-hyuk Lee), a leading specialist in manufacturing and industrial solutions, is poised to dominate the MLOps (Machine L...

2022-11-15 00:00 3167

AIRS Medical showcases award-winning MRI enhancement AI solution at RSNA 2022

SEOUL, South Korea, Nov. 14, 2022 /PRNewswire/ -- AIRS Medical, Inc., a leading medical AI solution provider, announced its participation in the 108th Scientific Assembly and Annual Meeting of the Radiological Society ofNorth America (RSNA 2022), the world's leading annual imaging forum at McC...

2022-11-14 23:00 2562

SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969

State-run financing to provide two-year support of Phase 1 research for oncology candidate, SKL27969, for the potential treatment of advanced solid tumors SK Biopharmaceuticals to present preclinical data on oncology candidate, SKL27969, at Society for Neuro-Oncology Conference PANGYO, South Ko...

2022-11-14 08:00 2547

The new THREAD LIFT with approved design patent "TIMEMACHINE LIFT THREAD, ANCHORING DUAL COG"

SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- Safe thread lifting without  surgery,the most representative lifting method with various advantages TIMEMACHINE LIFE THREAD Recently, with the development of various lifting proced...

2022-11-11 12:55 1980

J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Phase 1/2 IND approved by US FDA

- First patient expected in December 2022 SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small ...

2022-11-11 10:30 2312

LG Energy Solution Secures Multi-Year Lithium Carbonate Supply from Compass Minerals

* LGES to be supplied with 40 percent of Compass Minerals' annual lithium carbonate production over six years, expected to start in 2025 * The partnership embodies LGES's efforts in securing a stable critical mineral supply chain inNorth America while promoting a sustainable value chain SEOUL...

2022-11-11 07:00 2594

ALPINION MEDICAL SYSTEMS SHOWCASING THE LATEST INTELLIGENT ULTRASOUND TECHNOLOGY AT RSNA 2022

Unveiling Upgraded Top-Tier 'X-CUBE 90 on GPX' and Debuting Value Console 'X-CUBE 60' Unit Are Among the New-Generation of Diagnostic Ultrasound Systems to Be Demonstrated at the Radiological Society ofNorth America's Annual Medical Exhibition SEOUL, South Korea, Nov. 9, 2022 /PRNewswire/ -- ALP...

2022-11-10 04:50 2381

Amorepacific publishes its findings on dietary restrictions and lifespan extension in Nature Communications

* Discovered the effects of the essential amino acid, threonine, on promoting both life and healthspans. * Research findings will be applied to product development of its brand, VITAL BEAUTIE. SEOUL, South Korea, Nov. 8, 2022 /PRNewswire/ -- Amorepacific discovered a mechanism of dietary rest...

2022-11-08 22:00 1957

OP.GG Bot for Discord surpasses 10,000 installs

* OP.GG's new service that provides game data through Discord * Meaningful milestone a result of close collaboration with Discord since the development stages of the App Directory SEOUL, South Korea, Nov. 8, 2022 /PRNewswire/ -- Global game service platform OP.GG announced today that the OP.G...

2022-11-08 13:40 1683

STRADVISION Announces Strategic Reorganization Under New Business Units

* Reorganization aligns with company's continued efforts to better serve automotive customers from both the commercial and technology side * German Etlender joins as Head of Sales Engineering Team * Dean Beckman joins as Sales Director of Account Management Team * Bapu Kiranagi joins as Sol...

2022-11-08 00:00 2590
1 ... 54555657585960 ... 111

Week's Top Stories